Online citations, reference lists, and bibliographies.
← Back to Search

Efficacy Based On Tumor PD-L1 Expression In KEYNOTE-002, A Randomized Comparison Of Pembrolizumab (pembro; MK-3475) Versus Chemotherapy In Patients (pts) With Ipilimumab-refractory (IPI-R) Advanced Melanoma (MEL).

Igor Puzanov, Reinhard Dummer, Jacob Schachter, Anna C. Pavlick, Rene Gonzalez, Paolo Antonio Ascierto, Kim Allyson Margolin, Omid Hamid, Sanjiv S. Agarwala, Matteo S. Carlino, Jochen Utikal, Michal Lotem, Antoni Ribas, Peter Mohr, Charlotte M. Roach, Marisa Dolled-Filhart, Xiaoyun Nicole Li, Scot Ebbinghaus, Soonmo Peter Kang, Adil Daud

Save to my Library
Download PDF
Analyze on Scholarcy
Share